Fig. 1From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinibReceiver operating curves showing response to treatment and optimum cut-off values for triglyceride (A), total cholesterol (B), low density lipoprotein (C), and high density lipoprotein (D)Back to article page